1996
DOI: 10.1046/j.1526-4610.1996.3608511.x
|View full text |Cite
|
Sign up to set email alerts
|

Two More Secondary Headaches Mimicking Chronic Paroxysmal Hemicrania. Is This the Exception or the Rule?

Abstract: Two patients with headaches meeting the criteria of chronic paroxysmal hemicrania, as defined by the International Headache Society classification, are presented. Further investigations revealed parasellar pituitary microadenoma in the first patient and a maxillary cyst in the second. Surgical removal of the lesions resulted in complete relief from headaches. The clinical features of this rare syndrome are discussed and suggest that a more detailed laboratory study and clinical follow-up is necessary in patien… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
12
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 16 publications
2
12
0
Order By: Relevance
“…However, as the effect of indomethacin in CPH can be exerted at different doses, IHS criteria require an absolute effect at a dose of 150 mg daily or below. This is not the case in all reports presented in this review: in two cases (23, 32), indomethacin was ineffective; in five cases [31, 35 (case B), 37 (cases A and B), 40] the dose of indomethacin needed to obtain therapeutic effect was higher than 150 mg, ranging from 200 to 350 mg; in one case [36 (case A)] the dose of 75 mg was partly effective (but the higher dose was not tested), in two cases (25, 33), the dose of indomethacin was unspecified, and in four cases [24, 27 (case B), 28 (case A), 30] indomethacin was not administered. It is of interest that in two cases sumatriptan was effective (30, 31), unlike in genuine cases of CPH (41).…”
Section: Case Materialsmentioning
confidence: 71%
“…However, as the effect of indomethacin in CPH can be exerted at different doses, IHS criteria require an absolute effect at a dose of 150 mg daily or below. This is not the case in all reports presented in this review: in two cases (23, 32), indomethacin was ineffective; in five cases [31, 35 (case B), 37 (cases A and B), 40] the dose of indomethacin needed to obtain therapeutic effect was higher than 150 mg, ranging from 200 to 350 mg; in one case [36 (case A)] the dose of 75 mg was partly effective (but the higher dose was not tested), in two cases (25, 33), the dose of indomethacin was unspecified, and in four cases [24, 27 (case B), 28 (case A), 30] indomethacin was not administered. It is of interest that in two cases sumatriptan was effective (30, 31), unlike in genuine cases of CPH (41).…”
Section: Case Materialsmentioning
confidence: 71%
“…The case described by Sjaastad et al (6), according to comments from the authors, was a symptomatic CPH, which means that the algic symptoms caused by the tumour are identical to those seen in primary CPH patients. The same may be said about the cases described by Gatzonis et al (7). In the second case described by these authors, the presence of a maxillary cyst could hardly explain the CPH‐like symptoms and a complete pain relief was obtained after the surgical removal.…”
Section: Discussionmentioning
confidence: 62%
“…Some authors (8) claimed the involvement of structures in the cavernous sinus and the hypothalamic nuclei in the floor of the third ventricle were in the core of the pathophysiology of CPH. Cases with involvement of cavernous venous sinus or its vicinities (maxillary sinus, sella turcica) could lend support to this view (6–9).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…A 20‐year‐old man with PH for at least 1 year was found to have a microadenoma of cells producing TSH, ACTH and prolactin (6). His headache attacks fulfilled all but one of the ICHD‐II criteria for chronic PH, i.e.…”
Section: Discussionmentioning
confidence: 99%